Literature DB >> 12739012

Effect of combining nicotinamide as a PARS-inhibitor with selective iNOS blockade during porcine endotoxemia.

A Stehr1, F Ploner2, I Tugtekin3, M Matejovic4, M Theisen3, C Zülke5, M Georgieff3, P Radermacher3, K-W Jauch5.   

Abstract

OBJECTIVE: To investigate the effects of combined selective inducible nitric oxide synthase (iNOS) inhibition using 1400 W with nicotinamide (NAD) as a PARS-inhibitor on hepato-splanchnic hemodynamics, O(2) kinetics, and energy metabolism during hyperdynamic porcine endotoxemia.
DESIGN: Prospective, randomized, controlled, interventional experiment.
SETTING: Animal research laboratory.
SUBJECTS: Seventeen domestic pigs.
INTERVENTIONS: After 12 h of continuous i.v. endotoxin (LPS) infusion 17 pigs received either no drug (CON, n=9) or 1400 W, titrated to maintain mean arterial pressure (MAP) at pre-endotoxin level, plus 10 mg.kg.h NAD ( n=8;). Measurements were obtained before, 12 h, 18 h, and 24 h after starting LPS infusion. MEASUREMENTS AND
RESULTS: In addition to systemic and pulmonary hemodynamics and gas exchange, we measured hepatic arterial and portal venous blood flow, liver and portal venous drained viscera O(2) exchange, ileal mucosal-arterial PCO(2) gap, and portal as well as hepatic venous lactate/pyruvate ratios. Expired NO and plasma nitrate levels were assessed as a parameter of NO production. Without affecting cardiac output, therapy maintained MAP and blunted the LPS-induced rise in expired NO levels, attenuated the progressive fall in liver lactate clearance, and blunted the impairment of hepato-splanchnic redox state. The rise of ileal mucosal-arterial PCO(2) gap was not influenced.
CONCLUSIONS: Combining selective iNOS inhibition with NAD as a PARS blocker may prevent circulatory failure and attenuate the detrimental consequences of LPS in intestinal and hepatocellular energy metabolism. Given the potential hepatotoxicity of high-dose NAD treatment, more potent PARS blockers with higher selectivity might further enhance the benefit of this therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739012     DOI: 10.1007/s00134-003-1739-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  38 in total

Review 1.  Post-injury multiple organ failure: the role of the gut.

Authors:  H T Hassoun; B C Kone; D W Mercer; F G Moody; N W Weisbrodt; F A Moore
Journal:  Shock       Date:  2001-01       Impact factor: 3.454

2.  Simultaneous targeting or multiple pathways of shock: how promising, how novel?

Authors:  C Szabó
Journal:  Shock       Date:  1999-04       Impact factor: 3.454

3.  A new method for continuous intramucosal PCO2 measurement in the gastrointestinal tract.

Authors:  G Knichwitz; J Rötker; T Brüssel; M Kuhmann; N Mertes; T Möllhoff
Journal:  Anesth Analg       Date:  1996-07       Impact factor: 5.108

4.  Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs.

Authors:  A Wolfárd; J Kaszaki; C Szabó; Z Balogh; S Nagy; M Boros
Journal:  Eur Surg Res       Date:  1999       Impact factor: 1.745

5.  Norepinephrine and N(G)-monomethyl-L-arginine in hyperdynamic septic shock in pigs: effects on intestinal oxygen exchange and energy balance.

Authors:  K Träger; P Radermacher; K M Rieger; R Grover; A Vlatten; T Iber; J Adler; M Georgieff; B Santak
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

6.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

Authors:  B L Tepperman; J F Brown; B J Whittle
Journal:  Am J Physiol       Date:  1993-08

8.  Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock.

Authors:  A Szabó; A L Salzman; C Szabó
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite.

Authors:  C Szabó; B Zingarelli; A L Salzman
Journal:  Circ Res       Date:  1996-06       Impact factor: 17.367

10.  Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.

Authors:  C Szabó; G J Southan; C Thiemermann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more
  8 in total

Review 1.  Nicotinamide: a jack of all trades (but master of none?).

Authors:  Csaba Szabó
Journal:  Intensive Care Med       Date:  2003-04-24       Impact factor: 17.440

Review 2.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

3.  HMR1402, a potassium ATP channel blocker during hyperdynamic porcine endotoxemia: effects on hepato-splanchnic oxygen exchange and metabolism.

Authors:  Pierre Asfar; Zsolt Iványi; Hendrik Bracht; Balázs Hauser; Antje Pittner; Damian Vassilev; Marek Nalos; Xavier Maurice Leverve; Uwe Bernd Brückner; Peter Radermacher; Gebhard Fröba
Journal:  Intensive Care Med       Date:  2004-03-26       Impact factor: 17.440

4.  Inducible nitric oxide synthase inhibition improves intestinal microcirculatory oxygenation and CO2 balance during endotoxemia in pigs.

Authors:  Martin Siegemund; Jasper van Bommel; Lothar A Schwarte; Wolfgang Studer; Thierry Girard; Stephan Marsch; Peter Radermacher; Can Ince
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

5.  Plasma disappearance of indocyanine green: a marker for excretory liver function?

Authors:  Alexander Stehr; Franz Ploner; Karl Traeger; Marc Theisen; Carl Zuelke; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2005-10-18       Impact factor: 17.440

6.  C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Authors:  Pierre Kyme; Nils H Thoennissen; Ching Wen Tseng; Gabriela B Thoennissen; Andrea J Wolf; Kenichi Shimada; Utz O Krug; Kunik Lee; Carsten Müller-Tidow; Wolfgang E Berdel; W David Hardy; Adrian F Gombart; H Phillip Koeffler; George Y Liu
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

7.  Increased Mortality in Mice following Immunoprophylaxis Therapy with High Dosage of Nicotinamide in Burkholderia Persistent Infections.

Authors:  Sofiya N Micheva-Viteva; Brittany N Ross; Jun Gao; Samantha Adikari; Pengfei Zhang; Judith R Mourant; Terry H Wu; James H Werner; Alfredo G Torres; Elizabeth Hong-Geller
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

8.  Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages.

Authors:  Jason D Simmons; Glenna J Peterson; Monica Campo; Jenny Lohmiller; Shawn J Skerrett; Sorin Tunaru; Stefan Offermanns; David R Sherman; Thomas R Hawn
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.